P3 Health Partners Analyst Price Targets - Benzinga

P3 Health Partners Inc

PIIINASDAQ

Trade with Public

Trade with Public

$9.92

-0.39-3.78%

al cierre: Aug 26, 5:00 PM EST

$10.26

0.343.43%

After hour: Aug 20, 7:23 AM EST

Panorámica general Noticias Previsión de beneficios EventosPrecios objetivoFinanzas Sentimiento Propiedad Comparar Informe de acciones

P3 Health Partners Analyst Price Targets

Wall Street analyst price targets and consensus rating for P3 Health Partners (PIII).

Price Target Range — 8 Quarters

Analyst Consensus — 3 Analysts

1Buy

2Hold

Consensus RatingBuy# Analysts3Avg. Consensus PT$12Upside to Avg. PT+17.5%

Rating Trend — Last 9 Months

Recent Analyst Actions

View all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
May 22, 2026	TD Cowen	Ryan Langston	PT Raise	Hold	$3→$14
May 15, 2026	Lake Street	Ben Haynor	PT Raise	Buy	$4→$14
Apr 2, 2026	TD Cowen	Ryan Langston	PT Cut	Hold	$8→$3
Mar 27, 2026	Lake Street	Ben Haynor	PT Cut	Buy	$13→$4
Dec 12, 2025	BTIG	David Larsen	Suspends	Neutral	—
Nov 17, 2025	Lake Street	Ben Haynor	PT Cut	Buy	$20→$13
Aug 28, 2025	Lake Street	Ben Haynor	Assumes	Buy	$20
Apr 21, 2025	Lake Street	Brooks O'Neil	PT Cut	Buy	$50→$20
Nov 20, 2024	TD Cowen	Gary Taylor	PT Cut	Hold	$1→$0
Apr 1, 2024	BTIG	David Larsen	Downgrade	Buy→Neutral	—
Mar 14, 2024	Lake Street	Brooks O'Neil	PT Cut	Buy	$9→$5
Sep 1, 2023	BTIG	David Larsen	Initiate	Buy	$5

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
TD Cowen Maintains Hold on P3 Health Partners, Raises Price Target to $14

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and raises the price target from $3 to $14.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Raises Price Target to $14

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and raises the price target from $4 to $14.

Benzinga Newsdesk

PRO
TD Cowen Maintains Hold on P3 Health Partners, Lowers Price Target to $3

TD Cowen analyst Ryan Langston maintains P3 Health Partners (NASDAQ:PIII) with a Hold and lowers the price target from $8 to $3.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $4

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $12.5 to $4.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $12.5

Lake Street analyst Ben Haynor maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $20 to $12.5.

Benzinga Newsdesk

PRO
Lake Street Maintains Buy on P3 Health Partners, Lowers Price Target to $20

Lake Street analyst Brooks O'Neil maintains P3 Health Partners (NASDAQ:PIII) with a Buy and lowers the price target from $50 to $20.

Benzinga Newsdesk